Acute Onset Linear Lichen Planus Pigmentosus of the Forehead: A Case Series

January 2023 | Volume 22 | Issue 1 | 94 | Copyright © January 2023


Published online December 15, 2022

Elijah Rodriguez BAa, Seneca D. Hutson BSb, Lisa O. Akintilo MD MPHa, Shane Meehan MDa, Evan Rieder MDa, Prince Adotama MDa

aThe Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY
bLarner College of Medicine at The University of Vermont, Burlington, VT

Abstract

Linear lichen planus pigmentosus (LPP) of the face is a rare variant of lichen planus, with only a few cases published in the literature.1 It is an inflammatory condition with unknown etiology, characterized by blue-gray hyperpigmented macules, and tends to affect sun-exposed areas of the head and neck.1-4 The pathophysiology of linear lichen pigmentosus is poorly understood, though it is postulated to be caused by T-lymphocyte autoimmunity against keratinocytes.5-7 LPP more frequently affects middle age woman and skin phototypes III-VI.1,3 Treatment for linear LPP is difficult and there is no established first-line therapy; however, tacrolimus ointment, topical corticosteroids, and various systemic agents have shown to be effective in improving the appearance.3,8,9 Prior reports have characterized linear LPP that follows the lines of Blashko as more commonly affecting the trunk.1 We present three cases of linear lichen planus pigmentosus (LPP) of the forehead, a unique novel presentation of linear LPP of the face. One of our cases also provides supporting evidence for tacrolimus to be used as a preferred therapy to treat linear LPP of the face; however, more research is needed to support this claim. To our knowledge, this case series is the largest case series of linear lichen planus pigmentosus (LPP) of the forehead to be reported.

J Drugs Dermatol. 2023;22(1):94-97. doi:10.36849/JDD.7200

Citation: Rodriguez E, Hutson S, Akintilo L, et al. Acute onset linear lichen planus pigmentosus of the forehead: A case series. J Drugs Dermatol. 2023;22(1):94-97. doi: 10.36849/JDD.7200. 

INTRODUCTION

Linear lichen planus pigmentosus (LPP) of the face is a rare acquired variant of lichen planus, with only a few cases published in the literature.1 It is an inflammatory condition with unknown etiology, characterized by blue-gray hyperpigmented macules, and tends to affect sun-exposed areas of the head and neck.1-4 The pathophysiology of linear LPP is poorly understood, though it is postulated to be caused by T-lymphocyte autoimmunity against keratinocytes.5-7 Linear LPP more frequently affects middle aged women and skin phototypes III to VI.1,3 It has also been proposed to be associated with hepatitis C infection, ultraviolet (UV) radiation, and contact allergens.1,3,8 Treatment for linear LPP is difficult and there is no established first-line therapy; however, tacrolimus ointment, topical corticosteroids, and various systemic agents are effective in improving the appearance.3,8,9

Linear LPP tends to show a unilateral distribution and can present along the lines of Blashko and in areas of koebnerization. Prior reports have characterized linear LPP that follows the lines of Blashko as more commonly affecting the trunk. Only 3 cases of linear LPP of the face have been reported in the literature.1

We present 3 cases of linear lichen planus pigmentosus of the forehead along the lines of Blashko, a unique presentation of linear LPP of the face. One of our cases also provides supporting evidence for tacrolimus as a preferred therapy. To our knowledge, this case series is the largest case series of linear LPP of the forehead to be reported. We review the literature, clinical presentation, and management options available for this entity.

CASE REPORTS

Case 1
A 48-year-old man presented to the Ronald O. Perelman Department of Dermatology at NYU Grossman School of Medicine with a chief concern of 5 months of forehead discoloration (Figure 1). He denied itch, pain, and preceding trauma to the forehead. He had been using
Jamaican black